The Target ALS Annual Meeting
Forging collaborations on the cutting-edge of ALS research
The perfect time and place for ALS research
Each spring, the Target ALS Annual Meeting brings together members of our Innovation Ecosystem over three days to share the latest breakthroughs in ALS research, forge new collaborations, and drive progress toward effective treatments for ALS.
Our 2025 meeting had the largest attendance in history, with more than 960 attendees present from academic institutions, pharmaceutical and biotech companies, venture capital firms, and nonprofit organizations ( in-person and virtually) reflecting the growth of both the scientists we support and the impact our work has had on expanding ALS research.
Our 2025 Meeting Report:
From Barriers to Breakthroughs: Accelerating the Future of ALS Research for All.
The report offers a comprehensive overview of the groundbreaking science, bold conversations, and collaborative momentum that shaped our 2025 meeting in Boston.
What makes the Target ALS annual meeting so groundbreaking?
The Target ALS Annual Meeting is a highly collaborative ALS conference globally for both researchers and people invested in powering ALS research.
Researchers present their unpublished ongoing work that are on the cutting-edge, and receive real-time feedback from other experts in the field.
Our annual meeting invites stakeholders from across the globe, bringing together people who rarely get the chance to collaborate in one place. The connections forged in this setting have a real, measurable impact on the direction of ALS research.
How the Target ALS Annual Meeting sparks collaboration
Thank You to Our 2025 Meeting Sponsors
If your organization is interested in bringing your brand and impact to our next annual meeting, please reach out to learn more about corporate sponsorship opportunities.
Funded Consortia
Grant Opportunities
